Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels

NCT: NCT07565779 · COMPLETED

NCT IDNCT07565779
StatusCOMPLETED
Start Date2025-01-28
Completion2026-01-31

Brief Summary

Individuals with ESKD and treated with hemodialysis have a high mortality risk. Associative studies suggest a relationship between serum magnesium concentration and mortality risk. The influence of magnesium concentration on mortality risk is unknown. This pilot study will explore whether altering dialysate magnesium concentration in the presence of citrate will change serum magnesium concentrations.

Frequently Asked Questions

What is Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels?

Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels is a clinical trial registered under NCT07565779. Current status: COMPLETED.

What is the status of NCT07565779?

The current status of NCT07565779 (Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels) is: COMPLETED.

When did Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels start?

Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels started on 2025-01-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑